In addition, treatments for IDH and TP53 mutant gliomas are not uniform: Some patients undergo chemotherapy as their initial adjuvant therapy and others undergo concurrent chemotherapy and radiotherapy. This evidence concerns the gene TP53 and central nervous system cancer.